Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Carl Alving

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Macrophages

Procedures

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
31
Wassef, Nabila
29
Rao, Mangala
22
Matyas, Gary
21
Szebeni, Janos
18
Richards, Roberta
13
Glenn, Gregory
9
Savay, Sandor
9
Baranyi, Lajos
8
Rothwell, Stephen
8
Peachman, Kristina
6
Scharton-Kersten, Tanya
6
Bünger, Rolf
5
Birx, Deborah
5
Karasavvas, Nicos
5
Krzych, Urszula

Sign-in to see all Coauthors

Publications

TOP 3
Steers Nicholas J; Peachman Kristina K; McClain Sasha; Alving Carl R; Rao Mangala
Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
Steers Nicholas J; Peachman Kristina K; McClain Sasha R; Alving Carl R; Rao Mangala
Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.
Matyas Gary R; Beck Zoltan; Karasavvas Nicos; Alving Carl R
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Carl Alving (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Steers Nicholas J; Peachman Kristina K; McClain Sasha; Alving Carl R; Rao Mangala
Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
Vaccine 2009;27(49):6939-49.
2009: Steers Nicholas J; Peachman Kristina K; McClain Sasha R; Alving Carl R; Rao Mangala
Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.
Journal of virology 2009;83(14):7049-61.
2009: Matyas Gary R; Beck Zoltan; Karasavvas Nicos; Alving Carl R
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1.
Biochimica et biophysica acta 2009;1788(3):660-5.
2008: Beck Zoltan; Karasavvas Nicos; Matyas Gary R; Alving Carl R
Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.
Journal of drug targeting 2008;16(7):535-42.
2008: Karasavvas Nicos; Beck Zoltan; Tong James; Matyas Gary R; Rao Mangala; McCutchan Francine E; Michael Nelson L; Alving Carl R
Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
Biochemical and biophysical research communications 2008;366(4):982-7.
2007: Beck Zoltan; Karasavvas Nicos; Tong James; Matyas Gary R; Rao Mangala; Alving Carl R
Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate.
Biochemical and biophysical research communications 2007;354(3):747-51.
2007: Brown Bruce K; Karasavvas Nicos; Beck Zoltan; Matyas Gary R; Birx Deborah L; Polonis Victoria R; Alving Carl R
Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.
Journal of virology 2007;81(4):2087-91.
2007: Shivachandra Sathish B; Li Qin; Peachman Kristina K; Matyas Gary R; Leppla Stephen H; Alving Carl R; Rao Mangala; Rao Venigalla B
Multicomponent anthrax toxin display and delivery using bacteriophage T4.
Vaccine 2007;25(7):1225-35.
2007: Szebeni János; Alving Carl R; Rosivall László; Bünger Rolf; Baranyi Lajos; Bedöcs Péter; Tóth Miklós; Barenholz Yezheckel
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles.
Journal of liposome research 2007;17(2):107-17.
2006: Alving Carl R; Beck Zoltan; Karasavva Nicos; Matyas Gary R; Rao Mangala
HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
Molecular membrane biology 2006;23(6):453-65.
2006: Sathaliyawala Taheri; Rao Mangala; Maclean Danielle M; Birx Deborah L; Alving Carl R; Rao Venigalla B
Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.
Journal of virology 2006;80(15):7688-98.
2006: Szebeni János; Baranyi Lajos; Sávay Sándor; Bodó Michael; Milosevits János; Alving Carl R; Bünger Rolf
Complement activation-related cardiac anaphylaxis in pigs: role of C5a anaphylatoxin and adenosine in liposome-induced abnormalities in ECG and heart function.
American journal of physiology. Heart and circulatory physiology 2006;290(3):H1050-8.
2006: Shivachandra Sathish B; Rao Mangala; Janosi Laszlo; Sathaliyawala Taheri; Matyas Gary R; Alving Carl R; Leppla Stephen H; Rao Venigalla B
In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins.
Virology 2006;345(1):190-8.
2006: Peachman Kristina K; Rao Mangala; Alving Carl R; Burge Robert; Leppla Stephen H; Rao Venigalla B; Matyas Gary R
Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
Infection and immunity 2006;74(1):794-7.
2006: Alving Carl R
Antibodies to lipids and liposomes: immunology and safety.
Journal of liposome research 2006;16(3):157-66.
2005: Bodo Michael; Szebeni Janos; Baranyi Lajos; Savay Sandor; Pearce Frederick J; Alving Carl R; Bünger Rolf
Cerebrovascular involvement in liposome-induced cardiopulmonary distress in pigs.
Journal of liposome research 2005;15(1-2):3-14.
2005: Peachman Kristina K; Rao Mangala; Alving Carl R; Palmer Dupeh R; Sun Wellington; Rothwell Stephen W
Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens.
Immunobiology 2005;210(5):321-33.
2004: Richards Roberta L; Rao Mangala; Vancott Thomas C; Matyas Gary R; Birx Deborah L; Alving Carl R
Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen.
Immunology and cell biology 2004;82(5):531-8.
2004: Rao Mangala; Matyas Gary R; Vancott Thomas C; Birx Deborah L; Alving Carl R
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein.
Immunology and cell biology 2004;82(5):523-30.
2004: Peachman Kristina K; Rao Mangala; Palmer Dupeh R; Zidanic Michael; Sun Wellington; Alving Carl R; Rothwell Stephen W
Functional microtubules are required for antigen processing by macrophages and dendritic cells.
Immunology letters 2004;95(1):13-24.
2004: Moghimi S Moein; Hunter A Christy; Dadswell Christopher M; Savay Sandor; Alving Carl R; Szebeni Janos
Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels.
Biochimica et biophysica acta 2004;1689(2):103-13.
2004: Matyas Gary R; Rao Mangala; Pittman Phillip R; Burge Robert; Robbins Iris E; Wassef Nabila M; Thivierge Brandie; Alving Carl R
Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice.
Journal of immunological methods 2004;286(1-2):47-67.
2004: Matyas Gary R; Friedlander Arthur M; Glenn Gregory M; Little Stephen; Yu Jianmei; Alving Carl R
Needle-free skin patch vaccination method for anthrax.
Infection and immunity 2004;72(2):1181-3.
2003: Rao Mangala; Peachman Kristina K; Alving Carl R; Rothwell Stephen W
Depletion of cellular cholesterol interferes with intracellular trafficking of liposome-encapsulated ovalbumin.
Immunology and cell biology 2003;81(6):415-23.
2003: Peachman Kristina K; Rao Mangala; Alving Carl R
Immunization with DNA through the skin.
Methods (San Diego, Calif.) 2003;31(3):232-42.
2003: Szebeni Janos; Baranyi Lajos; Savay Sandor; Götze Otto; Alving Carl R; Bünger Rolf; Mongan Paul D
Complement activation during hemorrhagic shock and resuscitation in swine.
Shock (Augusta, Ga.) 2003;20(4):347-55.
2003: Chanan-Khan A; Szebeni J; Savay S; Liebes L; Rafique N M; Alving C R; Muggia F M
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(9):1430-7.
2003: Basta Milan; Van Goor Fredric; Luccioli Stefano; Billings Eric M; Vortmeyer Alexander O; Baranyi Lajos; Szebeni Janos; Alving Carl R; Carroll Michael C; Berkower Ira; Stojilkovic Stanko S; Metcalfe Dean D
F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
Nature medicine 2003;9(4):431-8.
2003: Szebeni Janos; Baranyi Lajos; Savay Sandor; Milosevits Janos; Bodo Michael; Bunger Rolf; Alving Carl R
The interaction of liposomes with the complement system: in vitro and in vivo assays.
Methods in enzymology 2003;373():136-54.
2003: Matyas Gary R; Muderhwa Jean M; Alving Carl R
Oil-in-water liposomal emulsions for vaccine delivery.
Methods in enzymology 2003;373():34-50.
2003: Rao Mangala; Rothwell Stephen W; Alving Carl R
Trafficking of liposomal antigens to the trans-Golgi complex in macrophages.
Methods in enzymology 2003;373():16-33.
2002: Rao Mangala; Bray Mike; Alving Carl R; Jahrling Peter; Matyas Gary R
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
Journal of virology 2002;76(18):9176-85.
2002: Matyas Gary R; Rao Mangala; Alving Carl R
Induction and detection of antibodies to squalene. II. Optimization of the assay for murine antibodies.
Journal of immunological methods 2002;267(2):119-29.
2002: Alving Carl R
Design and selection of vaccine adjuvants: animal models and human trials.
Vaccine 2002;20 Suppl 3():S56-64.
2002: Güereña-Burgueño Fernando; Hall Eric R; Taylor David N; Cassels Frederick J; Scott Daniel A; Wolf Marcia K; Roberts Zachary J; Nesterova Galina V; Alving Carl R; Glenn Gregory M
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.
Infection and immunity 2002;70(4):1874-80.
2002: Yu Jianmei; Cassels Frederick; Scharton-Kersten Tanya; Hammond Scott A; Hartman Antoinette; Angov Evelina; Corthésy Blaise; Alving Carl; Glenn Gregory
Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Infection and immunity 2002;70(3):1056-68.
2002: Szebeni J; Baranyi L; Savay S; Milosevits J; Bunger R; Laverman P; Metselaar J M; Storm G; Chanan-Khan A; Liebes L; Muggia F M; Cohen R; Barenholz Y; Alving C R
Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies.
Journal of liposome research 2002;12(1-2):165-72.
2002: Savay Sandor; Szebeni Janos; Baranyi Lajos; Alving Carl R
Potentiation of liposome-induced complement activation by surface-bound albumin.
Biochimica et biophysica acta 2002;1559(1):79-86.
2001: Szebeni J; Alving C R; Savay S; Barenholz Y; Priev A; Danino D; Talmon Y
Formation of complement-activating particles in aqueous solutions of Taxol: possible role in hypersensitivity reactions.
International immunopharmacology 2001;1(4):721-35.
2001: Hammond S A; Walwender D; Alving C R; Glenn G M
Transcutaneous immunization: T cell responses and boosting of existing immunity.
Vaccine 2001;19(17-19):2701-7.
2000: Glenn G M; Taylor D N; Li X; Frankel S; Montemarano A; Alving C R
Transcutaneous immunization: a human vaccine delivery strategy using a patch.
Nature medicine 2000;6(12):1403-6.
2000: Matyas G R; Wassef N M; Rao M; Alving C R
Induction and detection of antibodies to squalene.
Journal of immunological methods 2000;245(1-2):1-14.
2000: Rothwell S W; Wassef N M; Alving C R; Rao M
Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway.
Immunology letters 2000;74(2):141-52.
2000: Szebeni J; Baranyi L; Savay S; Bodo M; Morse D S; Basta M; Stahl G L; Bünger R; Alving C R
Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction.
American journal of physiology. Heart and circulatory physiology 2000;279(3):H1319-28.
2000: Scharton-Kersten T; Yu J m; Vassell R; O'Hagan D; Alving C R; Glenn G M
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.
Infection and immunity 2000;68(9):5306-13.
1999: Muderhwa J M; Matyas G R; Spitler L E; Alving C R
Oil-in-water liposomal emulsions: characterization and potential use in vaccine delivery.
Journal of pharmaceutical sciences 1999;88(12):1332-9.
1999: Scharton-Kersten T; Glenn G M; Vassell R; Yu J; Walwender D; Alving C R
Principles of transcutaneous immunization using cholera toxin as an adjuvant.
Vaccine 1999;17 Suppl 2():S37-43.
1999: Rao M; Matyas G R; Grieder F; Anderson K; Jahrling P B; Alving C R
Cytotoxic T lymphocytes to Ebola Zaire virus are induced in mice by immunization with liposomes containing lipid A.
Vaccine 1999;17(23-24):2991-8.
1999: Glenn G M; Scharton-Kersten T; Alving C R
Advances in vaccine delivery: transcutaneous immunisation.
Expert opinion on investigational drugs 1999;8(6):797-805.
1999: Szebeni J; Fontana J L; Wassef N M; Mongan P D; Morse D S; Dobbins D E; Stahl G L; Bünger R; Alving C R
Hemodynamic changes induced by liposomes and liposome-encapsulated hemoglobin in pigs: a model for pseudoallergic cardiopulmonary reactions to liposomes. Role of complement and inhibition by soluble CR1 and anti-C5a antibody.
Circulation 1999;99(17):2302-9.
1999: Glenn G M; Scharton-Kersten T; Vassell R; Matyas G R; Alving C R
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Infection and immunity 1999;67(3):1100-6.
1999: Szebeni J; Alving C R
Complement-mediated acute effects of liposome-encapsulated hemoglobin.
Artificial cells, blood substitutes, and immobilization biotechnology 1999;27(1):23-41.
1999: Rao M; Rothwell S W; Wassef N M; Koolwal A B; Alving C R
Trafficking of liposomal antigen to the trans-Golgi of murine macrophages requires both liposomal lipid and liposomal protein.
Experimental cell research 1999;246(1):203-11.
1998: Glenn G M; Scharton-Kersten T; Vassell R; Mallett C P; Hale T L; Alving C R
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(7):3211-4.
1998: Richards R L; Rao M; Wassef N M; Glenn G M; Rothwell S W; Alving C R
Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen.
Infection and immunity 1998;66(6):2859-65.
1998: Glenn G M; Rao M; Matyas G R; Alving C R
Skin immunization made possible by cholera toxin.
Nature 1998;391(6670):851.
1998: Szebeni J; Muggia F M; Alving C R
Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study.
Journal of the National Cancer Institute 1998;90(4):300-6.
1998: VanCott T C; Kaminski R W; Mascola J R; Kalyanaraman V S; Wassef N M; Alving C R; Ulrich J T; Lowell G H; Birx D L
HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):2000-12.
1998: Le T P; Church L W; Corradin G; Hunter R L; Charoenvit Y; Wang R; de la Vega P; Sacci J; Ballou W R; Kolodny N; Kitov S; Glenn G M; Richards R L; Alving C R; Hoffman S L
Immunogenicity of Plasmodium falciparum circumsporozoite protein multiple antigen peptide vaccine formulated with different adjuvants.
Vaccine 1998;16(2-3):305-12.
1997: Rao M; Rothwell S W; Wassef N M; Pagano R E; Alving C R
Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages.
Immunology letters 1997;59(2):99-105.
1997: Alving C R; Szebeni J
Policing function of complement: through the body with gun and camera.
The Journal of laboratory and clinical medicine 1997;130(2):123-5.
1997: Szebeni J; Spielberg H; Cliff R O; Wassef N M; Rudolph A S; Alving C R
Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1.
Artificial cells, blood substitutes, and immobilization biotechnology 1997;25(4):347-55.
1997: Pye D; Vandenberg K L; Dyer S L; Irving D O; Goss N H; Woodrow G C; Saul A; Alving C R; Richards R L; Ballou W R; Wu M J; Skoff K; Anders R F
Selection of an adjuvant for vaccination with the malaria antigen, MSA-2.
Vaccine 1997;15(9):1017-23.
1997: Szebeni J; Wassef N M; Hartman K R; Rudolph A S; Alving C R
Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1.
Transfusion 1997;37(2):150-9.
1996: Szebeni J; Wassef N M; Rudolph A S; Alving C R
Complement activation in human serum by liposome-encapsulated hemoglobin: the role of natural anti-phospholipid antibodies.
Biochimica et biophysica acta 1996;1285(2):127-30.
1996: Richards R L; Alving C R; Wassef N M
Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity.
Journal of pharmaceutical sciences 1996;85(12):1286-9.
1996: Heppner D G; Gordon D M; Gross M; Wellde B; Leitner W; Krzych U; Schneider I; Wirtz R A; Richards R L; Trofa A; Hall T; Sadoff J C; Boerger P; Alving C R; Sylvester D R; Porter T G; Ballou W R
Safety, immunogenicity, and efficacy of Plasmodium falciparum repeatless circumsporozoite protein vaccine encapsulated in liposomes.
The Journal of infectious diseases 1996;174(2):361-6.
1996: Alving C R; Swartz G M; Wassef N M; Ribas J L; Herderick E E; Virmani R; Kolodgie F D; Matyas G R; Cornhill J F
Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induced hypercholesterolemia and plaque formation.
The Journal of laboratory and clinical medicine 1996;127(1):40-9.
1995: Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter R L; Glenn G; Alving C R; Church P; Hoffman S L
Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1637.
1995: Glenn G M; Rao M; Richards R L; Matyas G R; Alving C R
Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.
Immunology letters 1995;47(1-2):73-8.
1995: Rao M; Wassef N M; Alving C R; Krzych U
Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen.
Infection and immunity 1995;63(7):2396-402.
1995: Alving C R
Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity.
Annals of the New York Academy of Sciences 1995;754():143-52.
1995: Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter R L; Glenn G; Alving C R; Church P; Hoffman S L
Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(6):2784-93.
1995: Szebeni J; Wassef N M; Rudolph A S; Alving C R
Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination.
Artificial cells, blood substitutes, and immobilization biotechnology 1995;23(3):355-63.
1994: Szebeni J; Wassef N M; Spielberg H; Rudolph A S; Alving C R
Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation.
Biochemical and biophysical research communications 1994;205(1):255-63.
1994: Wassef N M; Alving C R; Richards R L
Liposomes as carriers for vaccines.
ImmunoMethods 1994;4(3):217-22.
1993: White K; Krzych U; Gordon D M; Porter T G; Richards R L; Alving C R; Deal C D; Hollingdale M; Silverman C; Sylvester D R
Induction of cytolytic and antibody responses using Plasmodium falciparum repeatless circumsporozoite protein encapsulated in liposomes.
Vaccine 1993;11(13):1341-6.
1993: Wassef N M; Alving C R
Complement-dependent phagocytosis of liposomes.
Chemistry and physics of lipids 1993;64(1-3):239-48.
1993: Alving C R; Detrick B; Richards R L; Lewis M G; Shafferman A; Eddy G A
Novel adjuvant strategies for experimental malaria and AIDS vaccines.
Annals of the New York Academy of Sciences 1993;690():265-75.
1993: Alving C R
Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants.
Immunobiology 1993;187(3-5):430-46.
1993: Wassef N M; Swartz G M; Alving B M; Alving C R
ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.
Biochemical and biophysical research communications 1993;190(2):582-8.
1992: Alving C R
Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens.
Biochimica et biophysica acta 1992;1113(3-4):307-22.
1992: Verma J N; Rao M; Amselem S; Krzych U; Alving C R; Green S J; Wassef N M
Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages.
Infection and immunity 1992;60(6):2438-44.
1992: Alving C R; Verma J N; Rao M; Krzych U; Amselem S; Green S M; Wassef N M
Liposomes containing lipid A as a potent non-toxic adjuvant.
Research in immunology 1992;143(2):197-8.
1992: Fries L F; Gordon D M; Richards R L; Egan J E; Hollingdale M R; Gross M; Silverman C; Alving C R
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(1):358-62.
1991: Verma J N; Wassef N M; Wirtz R A; Atkinson C T; Aikawa M; Loomis L D; Alving C R
Phagocytosis of liposomes by macrophages: intracellular fate of liposomal malaria antigen.
Biochimica et biophysica acta 1991;1066(2):229-38.
1991: Alving C R
Liposomes as carriers of antigens and adjuvants.
Journal of immunological methods 1991;140(1):1-13.
1991: Wassef N M; Matyas G R; Alving C R
Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids.
Biochemical and biophysical research communications 1991;176(2):866-74.
1991: Alving C R; Swartz G M
Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity.
Critical reviews in immunology 1991;10(5):441-53.
1990: Alving C R; Richards R L
Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.
Immunology letters 1990;25(1-3):275-9.
1990: Banerji B; Alving C R
Antibodies to liposomal phosphatidylserine and phosphatidic acid.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1990;68(1):96-101.
1990: Wassef N M; Swartz G M; Alving C R; Kates M
Antibodies to liposomal phosphatidylcholine and phosphatidylsulfocholine.
Biochemistry and cell biology = Biochimie et biologie cellulaire 1990;68(1):54-8.
1990: Alving C R
Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging.
Progress in clinical and biological research 1990;343():41-51.
1989: Richards R L; Swartz G M; Schultz C; Hayre M D; Ward G S; Ballou W R; Chulay J D; Hockmeyer W T; Berman S L; Alving C R
Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A.
Vaccine 1989;7(6):506-12.
1989: Wassef N M; Johnson S H; Graeber G M; Swartz G M; Schultz C L; Hailey J R; Johnson A J; Taylor D G; Ridgway R L; Alving C R
Anaphylactoid reactions mediated by autoantibodies to cholesterol in miniature pigs.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(9):2990-5.
1989: Alving C R; Swartz G M; Wassef N M
Naturally occurring autoantibodies to cholesterol in humans.
Biochemical Society transactions 1989;17(4):637-9.
1989: Wassef N M; Richards R L; Hayre M D; Alving C R
Prostaglandin and thromboxane in liposomes: suppression of the primary immune response to liposomal antigens.
Biochemical and biophysical research communications 1989;160(2):565-72.
1989: Gilbreath M J; Fogler W E; Swartz G M; Alving C R; Meltzer M S
Inhibition of interferon gamma-induced macrophage microbicidal activity against Leishmania major by liposomes: inhibition is dependent upon composition of phospholipid headgroups and fatty acids.
International journal of immunopharmacology 1989;11(2):103-10.
1988: Richards R L; Hayre M D; Hockmeyer W T; Alving C R
Liposomes as carriers for a human malaria sporozoite vaccine.
Biochemical Society transactions 1988;16(6):921-2.
1988: Richards R L; Hayre M D; Hockmeyer W T; Alving C R
Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.
Infection and immunity 1988;56(3):682-6.
1988: Swartz G M; Gentry M K; Amende L M; Blanchette-Mackie E J; Alving C R
Antibodies to cholesterol.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(6):1902-6.
1987: Richardson E C; Alving C R
Radioprotective effects of lipid A, liposomes, and liposomes containing lipid A in mice.
Biochimica et biophysica acta 1987;903(3):519-24.
1987: Fogler W E; Swartz G M; Alving C R
Antibodies to phospholipids and liposomes: binding of antibodies to cells.
Biochimica et biophysica acta 1987;903(2):265-72.
1986: Gilbreath M J; Hoover D L; Alving C R; Swartz G M; Meltzer M S
Inhibition of lymphokine-induced macrophage microbicidal activity against Leishmania major by liposomes: characterization of the physicochemical requirements for liposome inhibition.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(5):1681-7.
1986: Alving C R; Richards R L; Moss J; Alving L I; Clements J D; Shiba T; Kotani S; Wirtz R A; Hockmeyer W T
Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen.
Vaccine 1986;4(3):166-72.
1985: Wassef N M; Richardson E C; Alving C R
Specific binding of concanavalin A to free inositol and liposomes containing phosphatidylinositol.
Biochemical and biophysical research communications 1985;130(1):76-83.
1985: Gilbreath M J; Nacy C A; Hoover D L; Alving C R; Swartz G M; Meltzer M S
Macrophage activation for microbicidal activity against Leishmania major: inhibition of lymphokine activation by phosphatidylcholine-phosphatidylserine liposomes.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(5):3420-5.
1985: Gilbreath M J; Swartz G M; Alving C R; Nacy C A; Hoover D L; Meltzer M S
Differential inhibition of macrophage microbicidal activity by liposomes.
Infection and immunity 1985;47(2):567-9.
1984: Wassef N M; Roerdink F; Swartz G M; Lyon J A; Berson B J; Alving C R
Phosphate-binding specificities of monoclonal antibodies against phosphoinositides in liposomes.
Molecular immunology 1984;21(10):863-8.
1984: Wassef N M; Roerdink F; Richardson E C; Alving C R
Suppression of phagocytic function and phospholipid metabolism in macrophages by phosphatidylinositol liposomes.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(9):2655-9.
1983: Roerdink F; Wassef N M; Richardson E C; Alving C R
Effects of negatively charged lipids on phagocytosis of liposomes opsonized by complement.
Biochimica et biophysica acta 1983;734(1):33-9.
1980: Alving C R; Banerji B; Shiba T; Kotani S; Clements J D; Richards R L
Liposomes as vehicles for vaccines.
Progress in clinical and biological research 1980;47():339-55.

Sign-in to see more